# PM1183-B-005-14 (NCT02454972)

> Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02454972
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: PharmaMar
- Conditions: Advanced Solid Tumors
- Interventions: lurbinectedin (PM01183)
- Enrollment: 345
- Primary outcome: Overall Response Rate (ORR)
- Primary outcome: Response by Investigator Assessment

## Indexed commentary on PM1183-B-005-14 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 4

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=pm1183-b-005-14-nct02454972